CD19.CAR T cells versus obinutuzumab-who will win the race for use in deep B cell depletion therapy in systemic autoimmunity?
作者信息
Kvacskay Peter, Merkt Wolfgang
机构信息
Department of Hematology, Oncology and Rheumatology, Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
出版信息
Rheumatology (Oxford). 2024 Sep 1;63(9):2317-2318. doi: 10.1093/rheumatology/keae144.
PMID:38460183
Abstract
摘要
Zotero 插件